The activity and expression of thymidine phosphorylase in human solid tumours.
about
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignanciesExpression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumorsThymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinomaExpression of uridine and thymidine phosphorylase genes in human breast carcinomaImpact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesisDevelopment and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase.Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancerThymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer.Factors promoting tumor angiogenesis.A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumorsPharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsGlycation of glutamate cysteine ligase by 2-deoxy-d-ribose and its potential impact on chemoresistance in glioblastoma.Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in miceHeterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistanceTherapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells.Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancerPhase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer.Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancerExpression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinomaInduction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.The cytosol activity of thymidine phosphorylase in endometrial cancer.A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer.Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap.The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus.TAS-102: a novel antimetabolite for the 21st century.A novel antimetabolite: TAS-102 for metastatic colorectal cancer.Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.Protection against DNA damage-induced apoptosis by the angiogenic factor thymidine phosphorylase.Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues.Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer.Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
P2860
Q26777679-BBEB29C4-ADE3-4737-958F-CA8B748C19F0Q28143681-21F534BE-CD0E-4665-A45A-FDA99F972C25Q28211052-2DE3DFB5-BA2B-48CA-AA4E-8BD67A790E54Q28216429-F6DA2EFA-ED7B-45A4-9FCB-27CCF610DC08Q28345390-3F4971AC-1B46-40A6-84CB-AD4B80A7328FQ31706439-5D8E757D-3A89-4858-998F-DD80293A4960Q33354817-B8958906-9A25-4846-BBC8-2DB2B8723542Q33758543-A104331B-413D-4FA5-8A09-933CE0A47E67Q33791689-827D34ED-C167-4BB0-94E0-9F59C3EE6C62Q33919101-E972FDDA-42CA-4377-B5C6-58B121CBECEDQ34008793-57E2D1ED-405D-4217-9514-F4EE5E39BB2BQ34037091-AF8EFD26-9504-43B9-B09B-5A1357BBB5ABQ34441342-89F30EFB-0FB8-4238-8292-34ACC581E7E3Q34536974-D89AFFFF-5F31-466F-8F73-06F27434DFBEQ34620205-D63B95C6-2519-4302-9397-3DD15F6EBFE8Q34786484-A10D02E9-21B1-4526-98FA-C71B49F6CF3FQ35588620-B9FF88D3-BF3E-4B7D-995B-95580585CF0AQ35765841-0489BE39-A904-438F-9CF3-8DEF157888E9Q35951880-DB0153B2-CF2B-417B-9BE1-F0ECD0ABD6A9Q36346309-33E0CDC1-7F47-42B5-8850-14229074D29CQ36617535-AC6F157D-F33C-4A02-B71C-32930345D888Q36618182-B60805C3-A64D-487F-B434-DDFE2FED502AQ36619868-47981754-1D52-4022-89CB-22DA3C9C30A7Q36621744-EB6F6A80-0937-413C-8959-2CA7393BA5F2Q36695264-3BFD40CC-194A-45D3-8A00-F74C27CFF1E8Q36986854-4511D9E9-BCF7-45B0-BF95-17064010FD95Q37294590-C2BDF335-A366-4DAA-AFAD-6D4ACD740356Q37309238-0E145F77-C60E-4191-8950-CCECD9D53C8CQ37389411-9BAE5E4F-E890-49C6-9F06-7F69A8B97475Q37406114-D95CDD97-3B97-4E50-B083-69054BB4B74FQ37415048-C8EF95E2-55D3-4093-8F81-636ACBD54CBBQ37421793-EA091850-7A8A-4EBB-B232-4963A8D3549FQ38472443-F8C07DFF-919B-49D5-B3DE-1D5DF2084743Q38652269-6718F5D0-E61E-4ED5-8C8D-91F40F3E0ACBQ38671965-79B3D866-0A62-4112-B8D1-01E2B16ADCFFQ40191193-B419984D-622F-4395-B96A-1087E21B5C08Q40320535-A28998D2-9EAD-40EC-812E-6D9C2F39C793Q40589399-96ACBE9C-A8EB-4CB8-A9D8-704130B97FCAQ43201962-823FF3A1-F484-462A-904C-BD1557D4E928Q43567347-56801712-97BC-4F5E-876F-F8BEDB61B8FC
P2860
The activity and expression of thymidine phosphorylase in human solid tumours.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The activity and expression of thymidine phosphorylase in human solid tumours.
@ast
The activity and expression of thymidine phosphorylase in human solid tumours.
@en
The activity and expression of thymidine phosphorylase in human solid tumours.
@nl
type
label
The activity and expression of thymidine phosphorylase in human solid tumours.
@ast
The activity and expression of thymidine phosphorylase in human solid tumours.
@en
The activity and expression of thymidine phosphorylase in human solid tumours.
@nl
prefLabel
The activity and expression of thymidine phosphorylase in human solid tumours.
@ast
The activity and expression of thymidine phosphorylase in human solid tumours.
@en
The activity and expression of thymidine phosphorylase in human solid tumours.
@nl
P2093
P1476
The activity and expression of thymidine phosphorylase in human solid tumours.
@en
P2093
Furukawa T
Kinoshita F
Miyadera K
Sumizawa T
Takebayashi Y
P304
P356
10.1016/0959-8049(96)00061-5
P577
1996-06-01T00:00:00Z